← Open Payments lookup

HANIA TOFIK: Open Payments

NPI 1609221175 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,619 in 56 payments from 9 companies in 2025. Trend: 2023 $977 · 2024 $1,487 · 2025 $1,619

Food & beverage: $1,619
CompanyPaymentsAmount
Madrigal Pharmaceuticals16$657
Gilead Sciences, Inc.8$186
ABBVIE INC.12$185
Janssen Biotech, Inc.4$180
Salix Pharmaceuticals, a division of Bausch Health US, LLC8$137
Phathom Pharmaceuticals, Inc.1$113
Takeda Pharmaceuticals U.S.A., Inc.3$79
Ipsen Biopharmaceuticals, Inc3$66
Intercept Pharmaceuticals, Inc.1$15

Products named: REZDIFFRA, TREMFYA, XIFAXAN, VOQUEZNA, SKYRIZI, IQIRVO, RINVOQ, ENTYVIO.

Industry payments across TX — which companies pay providers there.